LOGIN  |  REGISTER
Amneal Pharmaceuticals

Nephros (NASDAQ: NEPH) Stock Quote

Last Trade: US$2.27 0.06 2.71
Volume: 226
5-Day Change: 5.09%
YTD Change: -34.39%
Market Cap: US$23.930M

Latest News From Nephros

Full-Year Net Revenue of $14.2 Million and Fourth-Quarter Net Revenue of $3.3 Million SOUTH ORANGE, NJ, March 07, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the fourth quarter and fiscal year ended December 31, 2023. Financial Highlights Fourth Quarter... Read More
SOUTH ORANGE, NJ, Feb. 29, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its fourth quarter and fiscal year financial results on Thursday March 7, 2024 after market close and will host a conference call that same day at 4:30pm ET. Participants may dial into the... Read More
Third-Quarter Net Revenue of $3.7 Million, a 55% Increase Over 2022; Net Loss from Continuing Operations Narrows 85% to $0.2 Million; $1.1 Million in Positive Year-to-Date Net Cash Flows from Operating Activities SOUTH ORANGE, NJ, Nov. 08, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today... Read More
SOUTH ORANGE, NJ, Nov. 01, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, announced the appointment of Judy Krandel as Chief Financial Officer (CFO), effective today. In this role, Ms. Krandel will be responsible for directing the company’s finances and working closely with the Chief Executive... Read More
SOUTH ORANGE, NJ, Oct. 25, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its third-quarter financial results on Wednesday, November 8, 2023 after market close and will host a conference call that same day at 4:30pm ET. Participants may dial into the call as... Read More
Second-Quarter Net Revenue of $3.5 Million, a 24% Increase Over 2022; Year-to-Date Revenue Increases 45%; Maintains Positive Cash Flow Results SOUTH ORANGE, NJ, Aug. 09, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros , Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the second quarter ended June 30, 2023.... Read More
SOUTH ORANGE, NJ, July 26, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its second-quarter financial results on Wednesday, August 9, 2023 after market close and will host a conference call that same day at 4:30pm ET. Participants may dial into the call as... Read More
First-Quarter Net Revenue of $3.7 Million; Achieves Positive Cash Flow Months Earlier than Forecast SOUTH ORANGE, NJ, May 10, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros , Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the first quarter ended March 31, 2023. Financial Highlights * Net revenue from... Read More
Robert Banks to Be Named President and Chief Executive Officer; Andy Astor to Remain as Advisor and Interim Chief Financial Officer SOUTH ORANGE, NJ, May 08, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that Andy Astor, President and Chief Executive Officer, will retire in the... Read More
SOUTH ORANGE, NJ , April 26, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its first-quarter financial results on Wednesday, May 10, 2023 after market close and will host a conference call that same day at 4:30pm ET. Participants may dial into the call as... Read More
SOUTH ORANGE, NJ, April 04, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced preliminary revenue results for the quarter ended March 31, 2023. Nephros expects net revenue for the quarter ended March 31, 2023 to be approximately $3.7 million, a 69% increase from the quarter ended... Read More
Full-Year Net Revenue of $10 Million and Fourth Quarter Net Revenue of $2.6 Million SOUTH ORANGE, NJ, March 08, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the fourth quarter and fiscal year ended December 31, 2022. Financial Highlights Fourth Quarter... Read More
Donastar Becomes Exclusive Master Distributor of Nephros Commercial Water Filters for Food & Beverage and Hospitality Markets SOUTH ORANGE, NJ, March 01, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced a new partnership engaging Donastar Enterprises LLC as the exclusive master... Read More
SOUTH ORANGE, NJ, Feb. 22, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced it will file its fourth quarter and fiscal 2022 results on Wednesday, March 8, 2023 after market close and will host a conference call that same day at 4:30pm ET. Participants may dial into the call as... Read More
Fourth Quarter Net Revenue of $2.6 Million; Full-Year Net Revenue of $10.0 Million; Active Customer Sites Continue to Climb SOUTH ORANGE, NJ, Jan. 11, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced preliminary revenue results for the fourth quarter and fiscal year ended December... Read More
Chimerix

COPYRIGHT ©2023 HEALTH STOCKS HUB